Denali Therapeutics
DNLI
#3996
Rank
โ‚ฌ2.48 B
Marketcap
16,93ย โ‚ฌ
Share price
0.00%
Change (1 day)
-28.32%
Change (1 year)

EPS for Denali Therapeutics (DNLI)

EPS in 2025 (TTM): -2,61ย โ‚ฌ

According to Denali Therapeutics 's latest financial reports the company's current EPS (TTM) is -2,50ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -2,21ย โ‚ฌ a decrease over its 2023 EPS that were of -0,89ย โ‚ฌ.

EPS history for Denali Therapeutics from 2017 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-2,61ย โ‚ฌ17.92%
2024-2,21ย โ‚ฌ147.12%
2023-0,89ย โ‚ฌ-60%
2022-2,24ย โ‚ฌ8.79%
2021-2,06ย โ‚ฌ-712.82%
20200,34ย โ‚ฌ-118.93%
2019-1,77ย โ‚ฌ402.44%
2018-0,35ย โ‚ฌ-88.89%
2017-3,17ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novocure
NVCR
-1,38ย โ‚ฌ-44.67% Jersey
Novavax
NVAX
1,82ย โ‚ฌ-172.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
-9,91ย โ‚ฌ 295.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-6,11ย โ‚ฌ 143.99%๐Ÿ‡ฌ๐Ÿ‡ง UK